These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36218106)

  • 1. Assessment of COVID-19 vaccine booster dose acceptance, reluctance and concerns among elderly diabetes patients in Pakistan.
    Jaweed L; Ahmed Z; Ahmad SA; Imran M; Faraz S; Sahar T; Jaweed J; Maqsood MB; Ahmed S; Iqbal A; Khalid A; Ahmed S; Ishaqui AA
    Pak J Pharm Sci; 2022 Jul; 35(4(Special)):1269-1274. PubMed ID: 36218106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 booster dose acceptance, hesitancy and concerns among the elderly population: A cross-sectional study.
    Imran M; Ahmed Z; Ishaqui AA; Bafail D; Ahmad SA; Farooq J; Ali I; Mustafa B; Zehra T; Jaweed L; Kapadia S; Ahmed S; Ahmed S; Maqsood MB
    J Infect Dev Ctries; 2023 Nov; 17(11):1529-1536. PubMed ID: 38064396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge, acceptance, motivators and barriers of booster dose of COVID-19 vaccination among dental patients: A cross-sectional study.
    Faraz A; Hina M; Atif A; Sumbul D; Mahmood SE; Riaz F; Khan MS; Ahmad A; Ahmad MT; Parvez A; Zeyaullah M
    Medicine (Baltimore); 2023 Nov; 102(45):e35747. PubMed ID: 37960831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey.
    Moeed A; Najeeb H; Saleem A; Asghar MS; Rafi HM; Khattak AK; Bilal Z; Seboka BT
    Front Public Health; 2022; 10():911518. PubMed ID: 35844859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region.
    Ghazy RM; Abdou MS; Awaidy S; Sallam M; Elbarazi I; Youssef N; Fiidow OA; Mehdad S; Hussein MF; Adam MF; Abdullah FSA; Rebai WK; Raad EB; Hussein M; Shehata SF; Ismail II; Salam AA; Samhouri D
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia.
    Harapan H; Fathima R; Kusuma HI; Anwar S; Nalapraya WY; Wibowo A; Wati KDK; Medina A; Defrita AH; Astri Y; Prasetyowati A; Nurfarahin N; Khusna A; Oktariana S; Anwar S; Yussar MO; Khotimah S; Nainggolan BWM; Badri PRA; Argarini R; Winardi W; Indah R; Sallam M; Rajamoorthy Y; Wagner AL; Mudatsir M
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China.
    Ma L; Yang J; Zhang T; Han X; Huang Q; Yang Y; Feng L; Yang W; Wang C
    Hum Vaccin Immunother; 2022 Nov; 18(5):2049169. PubMed ID: 35417663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters.
    Rababa'h AM; Abedalqader NN; Ababneh M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7516-7525. PubMed ID: 34919254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China.
    Sun Y; Dai H; Wang P; Zhang X; Cui D; Huang Y; Zhang J; Xiang T
    Front Public Health; 2022; 10():914950. PubMed ID: 35903387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis.
    Mohamed MS; Mohamed AO; Alenazy R; Khan YH; Idriss MT; Alhudaib NAA; Elsaman T; Mohamed MA; Eltayib EM; Mallhi TH
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance, attitudes, and barriers of vaccine booster dose among nursing students: A multicounty survey.
    Al-Mugheed K; Al Rawajfah O; Bani-Issa W; Rababa M
    J Nurs Manag; 2022 Oct; 30(7):3360-3367. PubMed ID: 36064189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China.
    Qin C; Wang R; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():834572. PubMed ID: 35372197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.
    Wong LP; Alias H; Siaw YL; Muslimin M; Lai LL; Lin Y; Hu Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2078634. PubMed ID: 35648441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term adverse effects of COVID-19 vaccines after the first, second, and booster doses: a cross-sectional survey from Punjab, Pakistan, and the implications.
    Mustafa ZU; Maqbool F; Wahid M; Salman M; Haroon S; Khan YH; Mallhi TH; Godman B
    Rev Soc Bras Med Trop; 2023; 56():e0044. PubMed ID: 37283345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of COVID-19 Vaccine Acceptance and Reluctance Among Staff Working in Public Healthcare Settings of Saudi Arabia: A Multicenter Study.
    Maqsood MB; Islam MA; Al Qarni A; Nisa ZU; Ishaqui AA; Alharbi NK; Almukhamel M; Hossain MA; Fatani N; Mahrous AJ; Arab MA; Alfehaid FSA; Akbar Z
    Front Public Health; 2022; 10():847282. PubMed ID: 35712310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of COVID-19 Booster Dose among Saudi Arabian Population.
    Alshahrani NZ; Alsabaani AA; Ridda I; Rashid H; Alzahrani F; Almutairi TH; Alzahrani BAS; Albeshri ASS
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888690
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents - 19 States, March 29-July 25, 2022.
    McConeghy KW; White EM; Blackman C; Santostefano CM; Lee Y; Rudolph JL; Canaday D; Zullo AR; Jernigan JA; Pilishvili T; Mor V; Gravenstein S
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(39):1235-1238. PubMed ID: 36173757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China.
    Qin W; Zhang X; Wang Y; Pan F; Cheng K; Huang F; Song J; Su H
    Front Public Health; 2022; 10():943876. PubMed ID: 35979461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees.
    Attia S; Mausbach K; Klugar M; Howaldt HP; Riad A
    Front Public Health; 2022; 10():846861. PubMed ID: 35462827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.